Lakewood-Amedex Biotherapeutics
LABT
#11175
Rank
A$2.94 M
Marketcap
A$1.24
Share price
1.42%
Change (1 day)
N/A
Change (1 year)
Categories

Earnings for Lakewood-Amedex Biotherapeutics (LABT)

Earnings in 2026 (TTM): -A$10.61 Million

According to Lakewood-Amedex Biotherapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$5.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lakewood-Amedex Biotherapeutics from 2025 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$10.61 Million97.5%
2025 -A$5.37 Million